Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2021 1
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa.
Ghafuri DL, Covert Greene B, Musa B, Gambo A, Sani A, Abdullahi S, Wudil BJ, Bello-Manga H, Gambo S, Ghafuri M, Cassell H, Neville K, Kirkham F, Kassim AA, Aliyu MH, DeBaun MR, Jordan LC. Ghafuri DL, et al. Pediatr Neurol. 2021 Dec;125:9-15. doi: 10.1016/j.pediatrneurol.2021.08.010. Epub 2021 Sep 4. Pediatr Neurol. 2021. PMID: 34563875 Free PMC article. Clinical Trial.
Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
Galadanci NA, Abdullahi SU, Tabari MA, Abubakar S, Belonwu R, Salihu A, Neville K, Kirkham F, Inusa B, Shyr Y, Phillips S, Kassim AA, Jordan LC, Aliyu MH, Covert BV, DeBaun MR. Galadanci NA, et al. Pediatr Blood Cancer. 2015 Mar;62(3):395-401. doi: 10.1002/pbc.25289. Epub 2014 Nov 14. Pediatr Blood Cancer. 2015. PMID: 25399822 Free PMC article. Clinical Trial.
Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).
Galadanci NA, Umar Abdullahi S, Vance LD, Musa Tabari A, Ali S, Belonwu R, Salihu A, Amal Galadanci A, Wudil Jibir B, Bello-Manga H, Neville K, Kirkham FJ, Shyr Y, Phillips S, Covert BV, Kassim AA, Jordan LC, Aliyu MH, DeBaun MR. Galadanci NA, et al. Am J Hematol. 2017 Aug;92(8):780-788. doi: 10.1002/ajh.24770. Epub 2017 Jun 15. Am J Hematol. 2017. PMID: 28439953 Free PMC article. Clinical Trial.
Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.
Galadanci NA, Abdullahi SU, Ali Abubakar S, Wudil Jibir B, Aminu H, Tijjani A, Abba MS, Tabari MA, Galadanci A, Borodo AM, Belonwu R, Salihu AS, Rodeghier M, Ghafuri DL, Covert C Greene BV, Neville K, Kassim AA, Kirkham FJ, Jordan LC, Aliyu MH, DeBaun MR. Galadanci NA, et al. Am J Hematol. 2020 Sep;95(9):E247-E250. doi: 10.1002/ajh.25900. Epub 2020 Jul 10. Am J Hematol. 2020. PMID: 32510680 Free PMC article. Clinical Trial. No abstract available.